Semaglutide Beneficial for People With Obesity, Knee Osteoarthritis
By Elana Gotkine HealthDay Reporter
THURSDAY, Oct. 31, 2024 -- For individuals with obesity and knee osteoarthritis, once-weekly semaglutide yields greater reductions in body weight and pain related to knee osteoarthritis than placebo, according to a study published in the Oct. 31 issue of the New England Journal of Medicine.
Henning Bliddal, M.D., from the Copenhagen University Hospital at Bispebjerg and Frederiksberg in Denmark, and colleagues conducted a 68-week trial at 61 sites in 11 countries. Four hundred seven participants with obesity and a clinical and radiologic diagnosis of moderate knee osteoarthritis with at least moderate pain were randomly assigned to receive once-weekly subcutaneous semaglutide or placebo in a 2:1 ratio in addition to counseling on physical activity and a reduced-calorie diet.
The researchers found that from baseline to week 68, the mean change in body weight was −13.7 and −3.2 percent with semaglutide and placebo, respectively. At week 68, the mean change in the Western Ontario and McMaster Universities Osteoarthritis Index pain score was −41.7 and −27.5 points with semaglutide and placebo, respectively. Greater improvement in the 36-Item Short Form Health Survey physical-function score was seen for participants in the semaglutide group versus placebo group (mean change, 12.0 versus 6.5 points). The two groups had a similar incidence of serious adverse events.
"The findings support the use of once-weekly subcutaneous semaglutide at a dose of 2.4 mg for weight management and treatment of pain in persons with obesity and moderate-to-severe pain due to knee osteoarthritis," the authors write.
The study was funded by Novo Nordisk, the manufacturer of semaglutide.
Abstract/Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2024-11-01 06:00
Read more
- Nasal Swab Might Predict How Severe COVID Will Be
- Patients Living Outside Metropolitan Statistical Areas Travel Farther for Health Care Visits
- EPA Finalizes Tough New Standards on Lead Paint Dust
- Incidence of Dyslipidemia Elevated During COVID-19 Pandemic
- Racial, Ethnic Differences Seen in Cleft Lip Surgery Repair
- Prenatal Substance Exposure Plays Role in Sleep-Related Sudden Infant Death
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions